Eidelman Virant Capital Trimmed Its Kingstone Cos (KINS) Position; Aethlon Medical (AEMD) Sellers Decreased By 4.73% Their Shorts

September 7, 2017 - By Vivian Currie

Eidelman Virant Capital decreased Kingstone Cos Inc (KINS) stake by 8.35% reported in 2016Q4 SEC filing. Eidelman Virant Capital sold 24,405 shares as Kingstone Cos Inc (KINS)’s stock rose 8.42%. The Eidelman Virant Capital holds 267,857 shares with $3.68 million value, down from 292,262 last quarter. Kingstone Cos Inc now has $153.08M valuation. The stock decreased 0.69% or $0.1 during the last trading session, reaching $14.4. About shares traded. Kingstone Companies Inc (NASDAQ:KINS) has risen 64.08% since September 7, 2016 and is uptrending. It has outperformed by 47.38% the S&P500.

Aethlon Medical Incorporated (NASDAQ:AEMD) had a decrease of 4.73% in short interest. AEMD’s SI was 151,200 shares in September as released by FINRA. Its down 4.73% from 158,700 shares previously. With 15,000 avg volume, 10 days are for Aethlon Medical Incorporated (NASDAQ:AEMD)’s short sellers to cover AEMD’s short positions. The SI to Aethlon Medical Incorporated’s float is 2.05%. The stock increased 7.33% or $0.11 on September 6, reaching $1.61. About shares traded. Aethlon Medical, Inc. (NASDAQ:AEMD) has declined 56.57% since September 7, 2016 and is downtrending. It has underperformed by 73.27% the S&P500.

Eidelman Virant Capital increased Conifer Hldgs Inc stake by 205,545 shares to 493,461 valued at $2.92M in 2016Q4. It also upped L S B Industries Inc (NYSE:LXU) stake by 234,400 shares and now owns 1.01M shares. Tidewater Inc Citizn (NYSE:TDW) was raised too.

Investors sentiment decreased to 2.29 in Q4 2016. Its down 1.29, from 3.58 in 2016Q3. It turned negative, as 4 investors sold KINS shares while 5 reduced holdings. 7 funds opened positions while 7 raised stakes. 2.32 million shares or 28.81% more from 1.80 million shares in 2016Q3 were reported. Dimensional Fund Advsr LP accumulated 0% or 39,090 shares. Tower Research Cap Lc (Trc) owns 0% invested in Kingstone Companies Inc (NASDAQ:KINS) for 259 shares. Perritt Capital Management Incorporated reported 70,000 shares. Ativo Capital Mngmt Limited Liability Corp, Illinois-based fund reported 93,828 shares. Spark Mngmt Limited Liability Com holds 13,235 shares or 0.01% of its portfolio. Eidelman Virant Capital owns 2.1% invested in Kingstone Companies Inc (NASDAQ:KINS) for 267,857 shares. 499,629 were reported by Tcw Grp Inc. Wells Fargo And Mn has invested 0% of its portfolio in Kingstone Companies Inc (NASDAQ:KINS). Sit Investment Assoc holds 11,900 shares. Vanguard Group Inc Incorporated holds 193,919 shares or 0% of its portfolio. Deutsche Bank & Trust Ag invested in 27,358 shares. Renaissance Technology Lc invested in 100,800 shares. Stieven Capital Advsrs Limited Partnership has invested 0.58% in Kingstone Companies Inc (NASDAQ:KINS). Blackrock Fund reported 23,906 shares. Citigroup invested in 0% or 10 shares.

Aethlon Medical, Inc. is a medical device firm focused on creating devices for cancer, infectious disease and other life-threatening conditions. The company has market cap of $13.26 million. The Firm operates through two divisions: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. It currently has negative earnings. The Company’s lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression.